Michigan Technology Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Michigan Technology Journal.

Press releases published on April 2, 2026

Apr. 2, 2026

Kustomer Launches “Kustomer AI - Signals” to Turn Customer Intelligence Into Real-Time Action Across the CX Stack

Indeterminate GlobeNewswire

Apr. 2, 2026

VisionWave Converts Latin American Government Engagement into Initial Defense Order

Indeterminate GlobeNewswire

Apr. 2, 2026

Origin One’s Electronic Chain of Custody Form (eCCF) Platform Meets NLCP Requirements for Digital eCCF Systems

Indeterminate GlobeNewswire

Apr. 2, 2026

authID Announces Strategic Partnership with Formula5 to Deliver Biometric Identity Security for Microsoft-First Enterprises

Indeterminate GlobeNewswire

Apr. 2, 2026

Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma

Indeterminate GlobeNewswire

Apr. 2, 2026

Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer 

Indeterminate GlobeNewswire

Apr. 2, 2026

Roadzen to Present at Maxim Group’s “Powering the AI Revolution” Virtual Conference on Tuesday April 7, 2026 at 8:30am ET

Indeterminate GlobeNewswire

Apr. 2, 2026

Diginex Appoints Chief Operating Officer and Chief Administrative Officer to Accelerate Implementation of Business Strategy

Indeterminate GlobeNewswire

Apr. 2, 2026

Red Cat Secures New Orders for Black Widow™ Drones from NATO Ally

Indeterminate GlobeNewswire

Apr. 2, 2026

Plus Therapeutics Secures Highmark Coverage for CNSide® CSF Assay, Expanding Reimbursement to ~75 Million Covered Lives

Indeterminate GlobeNewswire

Apr. 2, 2026

Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer

Indeterminate GlobeNewswire

Apr. 2, 2026

Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections

Indeterminate GlobeNewswire

Apr. 2, 2026

Adagene Announces Pricing of US$70.0 Million Public Offering of ADSs

Indeterminate GlobeNewswire

Apr. 2, 2026

Microchip Technology Earns IEC 62443-4-1 ML2 Industrial Automation and Control System Certification

Indeterminate GlobeNewswire

Apr. 2, 2026

Cartesian Therapeutics Announces New Employment Inducement Grants

Indeterminate GlobeNewswire

Apr. 2, 2026

Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)

Indeterminate GlobeNewswire

Apr. 2, 2026

Wix Announces Preliminary Results of Modified Dutch Auction Tender Offer

Indeterminate GlobeNewswire

Apr. 2, 2026

L3Harris Selects Mercury To Provide Solid-State Data Recorders for SDA’s Tranche 3 Tracking Layer Satellites

Indeterminate GlobeNewswire

Apr. 2, 2026

Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Late-line Patients with Microsatellite Stable Colorectal Cancer Demonstrate Improved Durability of Response

Indeterminate GlobeNewswire

Apr. 2, 2026

Neutrolis Announces Positive First-in-Human Phase 1a Results from LIBERATE-I Trial of NTR-1011, a First-in-Class DNASE1L3 Fusion Protein

Indeterminate GlobeNewswire